Menu
Home
About Us
Mission & Vision
Members
Our Team
Media
Press Inquiries
Publications & Media
Become a Member
DONATE
Harm Reduction
Home
Posts
Harm Reduction
Research
8 Sep 2026
A Clinician’s Toolkit for Psychedelic-Assisted Therapy
Search for:
Categories
Research
(07)
Recent Posts
8 Sep 2026
3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial.
8 Sep 2026
3,4-Methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial
8 Sep 2026
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
8 Sep 2026
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
8 Sep 2026
The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD
Tags
boardofdirectors
Clinical Practice
Clinical Trials
councilofelders
Ethics
executivedirector
foundingmember
Harm Reduction
MDMA
member
Phase 2
Phase 3
Psychedelic-Assisted Therapy
PTSD
staff
Veterans & First Responders
Home
Search
Account
Sign in
Create an Account
Username or email
*
Password
*
Login
Lost your password?
Main Menu
Home
About Us
Mission & Vision
Members
Our Team
Media
Press Inquiries
Publications & Media
Become a Member
Search for: